Eli Lilly: Sticking With A $1000 Target Ahead Of Q3 Earnings, New Trading RangeSeeking Alpha • 09/21/24
Is Eli Lilly Stock A Buy After Snagging Approval For A New Eczema Drug?Investors Business Daily • 09/19/24
Eli Lilly Stock Up 21% in 6 Months: Time to Add to Your Portfolio?Zacks Investment Research • 09/17/24
Prediction: This Will Be the First Healthcare Stock to Join the Trillion-Dollar ClubThe Motley Fool • 09/17/24
Is Most-Watched Stock Eli Lilly and Company (LLY) Worth Betting on Now?Zacks Investment Research • 09/17/24
World's Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, ModernaBarrons • 09/15/24
FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic DermatitisPRNewsWire • 09/13/24
Eli Lilly invests $1.8 bln in Ireland sites to scale up Alzheimer's, obesity drug productionReuters • 09/12/24
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugsCNBC • 09/12/24